The IPAD Cohort Study: Insomnia and Positive Airway Pressure Adherence in Children and Adolescents
Recruiting now NCT07176767
Run by Lena Xiao · for 8 to 18 · All sexes
What this study is about
Positive Airway Pressure (PAP) is a treatment used to help people with sleep-disordered breathing, particularly those with obstructive sleep apnea (OSA). The device delivers pressurized air through a mask to keep the airways open during sleep, improving breathing and preventing interruptions in sleep. Studying how insomnia affects PAP adherence in children can help improve future treatments. However, no long-term studies have looked at this in children. Based on previous research, the investigators plan to conduct a study across multiple centers focusing on children with OSA starting PAP therapy. The study will explore how insomnia affects PAP adherence and how race and ethnicity play a role.
Who can join (things the study team will check)
✅ You may be able to join if…
- Children aged 8-18 years old
- Obstructive apnea-hypopnea index ≥ 5/hour on baseline diagnostic polysomnogram (PSG)
- Newly prescribed PAP therapy
🚫 You may not be able to join if…
- Developmental disability precluding ability to answer questionnaires
Where this trial is running
- British Columbia Children's Hospital, Vancouver, British Columbia, Canada
Who to contact
Lena J Xiao, MD MSc · 6048752345 · lena.xiao@cw.bc.ca
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT07176767.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.